Device Trial Radar · NCT04952909
The ShortCut™ Study Protocol
Last checked: Nov 19, 2026Latest source record: Feb 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Jan 21, 2022
Primary completion
Sep 30, 2023
Study completion Dec 31, 2023
Sponsor
- Lead sponsor
- Pi-cardiaNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 7, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Prospective, Multicenter, Non-Randomized, Single-Arm, Open-Label Clinical Study to Demonstrate the Safety and Effectiveness of the ShortCut™ device for splitting bioprosthetic aortic valve leaflets in patients who are presented for a valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) procedure for an approved ViV indication, and who are at risk for TAVR-induced coronary artery ostium obstruction.
Conditions
- Risk of Coronary Obstruction Following Transcatheter Aortic Valve Replacement (TAVR) Procedure
Interventions
ShortCut™Device
Splitting bioprosthetic aortic valve leaflets
Primary outcomes
What the sponsor says the trial is designed to measure.
- (Number of Patients With) ShortCut™ Device- and/or ShortCut™ Procedure-related Mortality and All Cause StrokeTime frame: Discharge or at 7 days post-procedure, whichever occurs first
- (Number of Patients With) Leaflet Splitting Success Using the ShortCut™ DeviceTime frame: Intra-procedure
Locations
23 sites in 5 countries. Site status is shown where the registry gives one.
Tucson Medical Center
Tucson, Arizona
Smidt Heart Institute Cedars-Sinai Medical
Los Angeles, California
Kaiser Permanente - San Francisco Medical Center
San Francisco, California
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.